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Abstract
Infantile hypertrophic pyloric stenosis (IHPS) has an incidence of 1–8 per 1000 live births and is
inherited as a complex sex-modified multifactorial trait with a striking male preponderance. Syndromic
and monogenic forms exist, and two loci have been identified. Infants present with vomiting due to
gastric-outlet obstruction caused by hypertrophy of the smooth muscle of the pylorus. A genome-wide
SNP-based high-density linkage scan was carried out on 81 IHPS pedigrees. Nonparametric and
parametric linkage analysis identified loci on chromosomes 11q14-q22 (Z  = 3.9, p < 0.0001;
HLOD  = 3.4, α = 0.34) and Xq23 (Z  = 4.3, p < 0.00001; HLOD  = 4.8, α = 0.56). The two
linked chromosomal regions each harbor functional candidate genes that are members of the canonical
transient receptor potential (TRPC) family of ion channels and have a potential role in smooth-muscle
control and hypertrophy.
Main Text
Infantile hypertrophic pyloric stenosis (IHPS [MIM #179010]) is the most common cause of
gastrointestinal obstruction in the first few months of life, with an incidence of 1–8 per 1000 live births
in the white population.  It typically presents in infants 2–6 weeks after birth with projectile vomiting,
weight loss, and dehydration. Surgical treatment by pyloromyotomy was introduced a century ago.
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A genetic predisposition to IHPS is well established. IHPS shows familial aggregation, and the classic
studies of Carter defined the disease as a paradigm for the multifactorial sex-modified threshold model
of inheritance, with affected males outnumbering females in a 4:1 ratio.  This male preponderance
was confirmed by later studies in various populations.  There is a striking variation in incidence
between population groups, with the cumulative incidence in American infants being 1.9 per 1000 live
births in whites, 1.8 in Hispanics, 0.7 in blacks, and 0.6 in Asians.
In a reanalysis of data from several studies, λ  (the ratio of the disease risk among patient siblings to
that among members of the general population) was estimated to be 18.  The same study concluded
that IHPS is determined by two or three loci of moderate effect conferring individual genotype relative
risks (GRRs) of up to 5.
IHPS has also been associated with several genetic syndromes, such as Cornelia de Lange  and Smith-
Lemli-Opitz  syndromes, and chromosomal abnormalities, including translocation of chromosome 8
and 17 and a partial trisomy of chromosome 9.  Autosomal-dominant monogenic forms of IHPS
have also been reported in several extended pedigrees.
A region on chromosome 16p13-p12 has been identified as the first locus for monogenic IHPS (IHPS2
[MIM #610260]).  A second locus for monogenic IHPS on chromosome 16q24 has since been
identified (K.V.E., F.C., C.G., B.A.C., A.R., A.P., P.P., R.M.G., and E.M.K.C., unpublished data). The
gene encoding neuronal nitric oxide synthase, NOS1 (MIM #163731), on chromosome 12q is also
considered to be an IHPS susceptibility locus (IHPS1 [MIM #179010]).
Environmental factors are clearly implicated in the development of IHPS. A period of postnatal enteral
feeding is required for the disease to develop. In addition, a recent decline in the incidence of IHPS that
parallels that of sudden infant death has been observed, coinciding with the implementation of the
“back to sleep campaign” . This has led to the suggestion that posture and feeding are two important
potentially modifiable environmental factors in IHPS. A further environmental factor in some cases is
erythromycin, a motilin agonist. A 7-fold increase in the incidence of IHPS has been reported among
newborn infants who had received erythromycin for postexposure pertussis prophylaxis.
Erythromycin binds to the motilin receptor, which is expressed in the enteric neurons of the duodenum
and colon, and induces intestinal contractions.  It is administered in low doses to improve gastric
emptying, but when used in higher doses as an antibiotic, it can lead to prolonged contraction and
hypertrophy.
The aim of this work was the identification of disease-predisposing loci with a genome-wide SNP-based
linkage scan in a resource of IHPS pedigrees. A SNP-based approach provides increased genomic
coverage and a greater overall information content in comparison to microsatellites.  A model-free
nonparametric analysis was initially performed, followed by specific parametric analyses.
Eighty-one pedigrees, all of European descent, were ascertained from the UK and Ireland via pediatric
units in four major centers: St George's Healthcare National Health Service (NHS) Trust, London;
Great Ormond Street Hospital for Children NHS Trust, London; Barts and the London NHS Trust; and
Our Lady's Children's Hospital, Dublin. There were a total of 302 individuals, with 206 affected. This
resource has sufficient power to detect loci of moderate effect in a subset of these pedigrees. Thirty-nine
families had two affecteds; 25 had three affecteds; seven had four affecteds; eight had five affecteds; and
two had seven affecteds. Full details are contained in the Supplemental Data available online. The ratio
of male to female affecteds was 3 to 1. The diagnosis in all cases was confirmed at pyloromyotomy. The
study was approved by the Ethics Committee of University College London Hospital and by the
appropriate local insitutional review boards at all other participating hospitals. Informed consent was
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obtained from all participating families.
Genomic DNA was extracted from cheek swab, saliva, or blood samples according to standard kits and
protocols (Oragene and Simhelix DNA Isolation kits). Samples were whole-genome ampliflied as
required with the REPLI-g kit. Of the total 302 individuals included in the study, whole-genome-
amplified DNA was used for 182 samples.
A genome-wide scan was carried out with the Illumina Linkage IV Panel of 6008 SNPs; 5942 SNPs
(98.9%) were successfully typed. These SNPs are designed to be evenly distributed throughout the
genome with an average genetic distance between SNPs of 0.64 cM and an average physical distance of
482 kb. Fifteen whole-genome amplification (WGA) samples (8.2%) could not be genotyped at all; none
of the genomic DNA samples failed completely. This genotyping was performed by Illumina, San Diego
CA.
Multipoint nonparametric linkage (NPL) analysis was performed with MERLIN 1.0.1. The Minx version
of this software was used for the analysis of the X chromosome data.  Thirteen of the 81 families in
the resource were excluded by the program from X chromosome analysis because no part of the
pedigree was consistent with X-linked inheritance (i.e., only male-to-male disease transmission
occurred). MERLIN 1.0.1 checks for and removes erroneous genotypes prior to analysis. Z scores were
derived at each SNP position along with a corresponding p value. The Z score is compared to a normal
distribution to test for deviation. The assumption of a normal distribution is conservative, as are the
associated p values.  Thresholds for suggestive evidence for linkage and significant evidence for
linkage were based on those proposed by Lander and Kruglyak  but are slightly less stringent.
Suggestive linkage in this study is defined by a p value less than 10 , and the threshold for significant
linkage is a p value less than 10 . These values are equivalent to one-tailed Z scores of 3.1 and 3.7,
respectively, which are themselves equivalent to maximized logarithm of odds (LOD) scores of 2.4 and
3.3.
The results of the multipoint NPL analysis for each chromosome are shown in Figure 1. The X
chromosome and chromosome 11 demonstrated significant evidence for linkage with an NPL Z  of
4.3 (p < 0.00001) for the X chromosome and an NPL Z  of 3.9 (p < 0.00005) for chromosome 11. A
comparison of Z  scores for each family for the “critical” regions on chromosome 11 and the X
chromosome is given in the Supplemental Data. The critical region is arbitrarily defined as extending to
where the Z score falls below 3. This is a conservative approach to defining the critical region so that no
possible candidate genes are overlooked. Most families were consistent with linkage to either
chromosome 11 or the X chromosome (or both); 12 families were not consistent with linkage to either
locus. An expanded view of each linked region is shown in Figure 2 and detailed in Tables 1 and 2.
Haplotypes were derived with the MERLIN 1.0.1 best-estimate approach, which is based on the most
likely pattern of gene flow. The pedigree structure and haplotypes for the linked regions for the most
informative families is given in the Supplemental Data. Suggestive evidence for linkage with a Z  of
3.1 (p < 0.001) was found at chromosome 22q11.1.
Parametric analysis, also with MERLIN 1.0.1, was performed on those genomic regions that showed
significant evidence for linkage with NPL analysis (chromosomes 11 and X). A disease allele frequency
of 0.001 and penetrance of 0.6 was assumed. A heterogeneity LOD score (HLOD) was derived at each
SNP position with a corresponding alpha, where α equals the proportion of families demonstrating
linkage to that locus.
Analysis of chromosome 11 with the assumption of autosomal-dominant inheritance demonstrated
significant evidence for linkage with a maximum HLOD (HLOD ) of 3.4 (α = 0.34). Analysis of the X
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chromosome with the assumption of X-linked recessive inheritance also demonstrated significant
evidence for linkage with an HLOD  of 4.8 (α = 0.56). Figure 2 shows the results of the NPL and
parametric analyses for these regions.
The genetic architecture of common familial traits that do not segregate in a Mendelian fashion is
beginning to emerge with the increased power provided by completion of the human-genome and
HapMap projects. As anticipated, the genetic basis of such complex traits covers a wide spectrum. The
number of loci involved (oligo- to polygenicity), their effect size and mode of interaction, and the
frequency and heterogeneity of causal alleles is clearly variable.  Linkage-analysis strategies remain a
valid approach for those traits for which there is reasonable expectation that loci of moderate effect
exist, provided that family resources adequate to offset the erosion of power engendered by locus
heterogeneity can be assembled.
Syndromic and monogenic forms of IHPS clearly exist, but the most common form segregates as a
complex multifactorial trait.  The male preponderance could not be explained solely by X-linked
recessive inheritance because male-to-male transmission is frequently observed. Two loci for
monogenic IHPS have been identified by SNP-based genome-wide scans in two different
multigeneration pedigrees consistent with autosomal dominant inheritance: chromosome 16p13-p12
(IHPS2 [MIM #610260])  and chromosome 16q24 (K.V.E., F.C., C.G., B.A.C., A.R., A.P., P.P., R.M.G.,
and E.M.K.C., unpublished data).
Suggestive evidence of linkage between IHPS and an intragenic microsatellite polymorphism in NOS1
(MIM #163731) on chromosome 12q24.2-q24.31 was shown with 27 IHPS families from our resource,
although this finding has not been replicated.  More recently, an association between IHPS and a
NOS1 promoter 1c regulatory polymorphism has been reported . The NOS1 gene encodes neuronal
nitric oxide synthase (nNOS), an enzyme that catalyzes the formation of nitric oxide (NO) in neurons of
the peripheral nervous system, where it plays a role in smooth-muscle relaxation. Transient pyloric
relaxation is essential for the passage of stomach contents into the small bowel, and this is mainly
mediated by the action of NO. A defect in NO production, leading to a failure of pyloric relaxation and
subsequent alteration of luminal transit, was therefore proposed to underlie at least some cases of
IHPS. NOS1-deficient mice are also reported to have features of IHPS.  Consequently, NOS1 is
considered to be a predisposing locus for IHPS (IHPS1 [MIM #179010]).
The statistical significance of linkage data generated by analysis of markers across the entire genome
remains controversial, but thresholds adopted merely determine the extent to which investigators wish
to tolerate false-positive results and waste resources in following up signals that have arisen by
chance.  Nonparametric analysis was adopted initially so that potential problems in mis-
specification of inheritance parameters could be avoided. A parametric analysis was then carried out in
those regions showing significant linkage. It can be argued that the similar results obtained suggest that
the parameters chosen might be close to the true pattern of inheritance at these loci.
Adopting significance thresholds corresponding to those proposed by Lander and Kruglyak,  we found
evidence for significant linkage at chromosome 11q14-q22 and Xq23, and suggestive evidence of linkage
was found at chromosome 22q. No evidence of linkage was obtained at the NOS1 locus (IHPS1 [MIM
#179010]) on chromosome 12q24 or at the loci for monogenic IHPS on chromosome 16. This does not
of course exclude that small-effect alleles at any of these loci might contribute to the trait in some or
even all of these pedigrees. It is consistent with the infrequency with which loci for Mendelian forms of
complex traits emerge as susceptibility loci for common cases. The results in any event confirm that
locus heterogeneity exists for IHPS.
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Linkage data from multiple small pedigrees segregating in a non-Mendelian fashion cannot reveal
unequivocal recombinant breakpoints that allow a clear definition of the critical linked region. On the
pragmatic assumption that the regions extend to where Z scores fall below 3.0, a region of
approximately 12 Mb on chromosome 11q14-q22 and approximately 2 Mb on chromosome Xq23 can be
defined. The former encompasses about 100 known or predicted genes and the latter about 12 genes.
Knowledge of the underlying pathophysiology of IHPS is sufficiently advanced to allow evaluation of
positional candidate genes within the critical regions according to their expression and putative
function. Information was collected from a number of human-genome resources including the Ensembl,
National Center for Biotechnology Information (NCBI), and University of California-Santa Cruz (UCSC)
Browsers (genome build NCBI36.1), in addition to the PubMed and Unigene databases.
Smooth-muscle hypertrophy in the pyloric canal underlies the gastric-outlet obstruction in IHPS. This
develops after birth and requires a period of enteral feeding.  IHPS appears to arise from a defect in
gastrointestinal motility that shows both development- and location-specific expression, rather than a
defect in the developmental anatomy of the gastrointestinal tract. It is noteworthy that each of these two
chromosomal regions harbors a gene from the same family of canonical transient receptor potential
(TRPC) cation channels: TRPC6 on chromosome 11q21-22 and TRPC5 on chromosome Xq23. These
genes represent the strongest functional candidate in each region.
Mammalian TRP proteins form a superfamily of 28 genes encoding six-transmembrane (6-TM)
permeable cation-channel subunits grouped into six subfamilies by amino acid sequence homology. TRP
channels are calcium-permeable cation channels and appear to act as signal integrators in a wide
variety of biological contexts.
The canonical TRP channel subfamily has seven members. TRPC channel expression tends to be
ubiquitous and abundant in brain and neural tissues, but TRPC5 and TRPC6 have been detected in
tissues of the gut and smooth muscle cells. TRPC6 is known to be highly expressed in pulmonary and
vascular smooth muscle, and a specific role in regulating smooth-muscle function is emerging for this
channel.  Overexpression of TRPC6 is implicated in increased pulmonary smooth-muscle
proliferation,  and it is possible that there might be a similar effect on the smooth muscle cells of the
pylorus. Furthermore, TRPC6 also acts as a sensor of membrane stretch,  which could be important in
the gastrointestinal tract for correct maintenance of peristalsis. TRPC6-deficient mice display increased
vascular smooth muscle contractility, indicating a role for TRPC6 in control of smooth-muscle tone.
Gain-of-function mutations in TRPC6 that enhance channel activity cause a proteinuric kidney disease,
focal and segmental glomerulosclerosis (FSGS),  but this does not exclude quite different pathology
arising from allelic variants with different functional effects.
TRPC5 is predominantly expressed in the brain, but it is also detected in smooth muscle cells and in
the stomach, where a role in gastrointestinal-tract muscle contraction has been proposed.  There is
evidence that TRPC5 might be involved in cardiac-muscle hypertrophy,  and it has been shown to be
activated by nitric oxide,  which is important in smooth-muscle relaxation in the gastrointestinal tract.
An X-linked recessive locus accounting for a subset of IHPS families could obviously contribute to the
male preponderance in IHPS. In our resource of familial and sporadic cases, the ratio of males to
females is more skewed among the sporadic population (3:1 and 5:1, respectively). It is difficult to
quantify the potential contribution of X-linked recessive inheritance to male preponderance in our
limited resource. However, within the pedigrees, the ratio of males to females is approximately 3.5:1 in
families consistent with linkage to Xq23 and 2.5:1 in families consistent with autosomal linkage.
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In conclusion, our results confirm locus heterogeneity for IHPS and identify loci on chromosomes 11q
and Xq. Strong functional candidate genes, TRPC5 and TRPC6, exist at these loci, and further work is
required for the evaluation of their putative role by resequencing and SNP-based association studies in
our resource of IHPS trios.
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Multipoint NPL Z Scores for All Chromosomes
Position refers to genetic distance from the telomere of the short arm of the chromosome.
Figure 2
NPL Z Score and Parametric HLOD Plots for the Linked Regions on Chromosomes 11 and X
NPL Z score and parametric HLOD plots for chromosome 11 (A) and the X chromosome (B) for the regions showing
evidence for linkage; position refers to genetic distance from the telomere of the short arm of the chromosome. Each
marked point corresponds to a genotyped SNP. The SNPs flanking the critical region are labeled. Chromosome 11 was
analyzed under the assumption of autosomal-dominant inheritance. Parametric analysis of the X chromosome assumed
X-linked recessive inheritance. Both analyses assumed a disease allele frequency of 0.001 and a reduced penetrance of
0.6. Also shown, with red lines, are the approximate positions of two candidate genes, TRPC6 and TRPC5.
Table 1
Linkage-Analysis Data for the Critical Region on Chromosome 11
SNP Physical Position (Mb) Genetic Position (cM) Z Score p Value
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rs586699 91929382 94.34 2.76 0.003
rs1944108 93103823 95.35 3.22 0.0006
rs584109 93652402 95.49 3.27 0.0005
rs541821 94801223 96.72 3.9 0.00005
rs1255182 95112039 97.29 3.75 0.00009
rs483884 95551040 98.09 3.64 0.00014
rs2919032 96132850 99.45 3.6 0.0002
rs921562 96806939 100.74 3.5 0.0002
rs723513 97588753 101.04 3.49 0.0002
rs1002122 99566587 102.71 3.47 0.0003
rs622675 100165933 103.12 3.41 0.0003
rs618291 100186421 103.121 3.41 0.0003
rs1943752 100601234 103.84 3.41 0.0003
rs948734 101434119 104.05 3.49 0.0002
rs1711399 101965987 104.33 3.5 0.0002
rs1784405 101975664 104.331 3.5 0.0002
rs1276278 102028851 104.37 3.5 0.0002
rs1298740 102057989 104.38 3.5 0.0002
rs536107 102404003 104.6 3.51 0.0002
rs601535 102605727 104.72 3.47 0.0003
rs559345 102802726 104.84 3.44 0.0003
rs540819 104371671 105.69 3.04 0.0012
rs1785872 104474890 105.79 2.99 0.0014
Table 2
Linkage-Analysis Data for the Critical Region on the X Chromosome
SNP Physical Position (Mb) Genetic Position (cM) Z Score p Value
rs2016878 109820582 105.91 2.91 0.002
rs1890141 110232670 106.32 4.18 0.00001
rs926412 110380673 106.47 4.19 0.00001
rs1016231 110619665 106.71 4.22 0.00001
rs3027802 110894171 106.99 4.26 0.00001
rs7049660 111445482 107.63 3.43 0.0003
rs2040497 111642086 108.3 2.85 0.002
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